{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:35:02Z","timestamp":1786736102386,"version":"build-2736575974"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi J Kidney Dis Transpl"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/1319-2442.270256","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T04:29:59Z","timestamp":1572928199000},"page":"1022","source":"Crossref","is-referenced-by-count":5,"title":["Correlation between serum sclerostin level and bone density status in children on regular hemodialysis"],"prefix":"10.4103","volume":"30","author":[{"given":"ManalAbd","family":"Elsalam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MahaZein","family":"El-Abden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZakiaAbo","family":"Zahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1319-2442.270256-1","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/ndt\/gft222","article-title":"Sclerostin in CKD-MBD: One more paradoxical bone protein?","author":"Jean","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.270256-2","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1093\/ndt\/gfp253","article-title":"Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification","author":"Sigrist","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.270256-3","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfp191","article-title":"High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients","author":"Jean","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.270256-4","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/ndt\/gfq144","article-title":"Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD","author":"Kovesdy","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.270256-5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00467-015-3069-7","article-title":"From skeletal to cardiovascular disease in 12 steps-the evolution of sclerostin as a major player in CKD-MBD","author":"Brandenburg","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.270256-6","first-page":"941419","article-title":"Sclerostin","author":"Silverman","year":"2010","journal-title":"J Osteoporos"},{"key":"key-10.4103\/1319-2442.270256-7","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1359\/jbmr.090411","article-title":"Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt\/beta-catenin signaling","author":"Lin","year":"2009","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/1319-2442.270256-8","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.05-4221fje","article-title":"Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation","author":"Poole","year":"2005","journal-title":"FASEB J"},{"key":"key-10.4103\/1319-2442.270256-9","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1074\/jbc.M705092200","article-title":"Mechanical stimulation of bone in vivo reduces osteocyte expression of sost\/sclerostin","author":"Robling","year":"2008","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1319-2442.270256-10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00198-011-1656-4","article-title":"Mechanical loading-related changes in osteocyte sclerostin expression in mice are more closely associated with the subsequent osteogenie response than the peak strains engendered","author":"Moustafa","year":"2012","journal-title":"Osteoporos Int"},{"key":"key-10.4103\/1319-2442.270256-11","doi-asserted-by":"crossref","unstructured":"Moester MJ, Papapoulos SE, L\u00f6wik CW, van Bezooijen RL. Sclerostin: Current knowledge and future perspectives. Calcif Tissue Int 2010;87:99-107.","DOI":"10.1007\/s00223-010-9372-1"},{"key":"key-10.4103\/1319-2442.270256-12","doi-asserted-by":"crossref","first-page":"24113","DOI":"10.1074\/jbc.M301716200","article-title":"Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity","author":"Kusu","year":"2003","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1319-2442.270256-13","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","author":"Li","year":"2005","journal-title":"J Biol Chem"},{"key":"key-10.4103\/1319-2442.270256-14","doi-asserted-by":"crossref","unstructured":"Viaene L, Behets GJ, Claes K, et al. Sclerostin: Another bone-related protein related to all-cause mortality in haemodialysis? Nephrol Dial Transplant 2013;28:3024-30.","DOI":"10.1093\/ndt\/gft039"},{"key":"key-10.4103\/1319-2442.270256-15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteo-dystrophy","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.270256-16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","author":"Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.270256-17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"key-10.4103\/1319-2442.270256-18","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","author":"Kidney","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/1319-2442.270256-19","first-page":"1","article-title":"2012 Clinical practice guideline for the evaluation and management of chronic kidney disease","author":"KDIGO","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"key-10.4103\/1319-2442.270256-20","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00198-008-0689-9","article-title":"Special report on the 2007 adult and pediatric position development conferences of the international society for clinical densitometry","author":"Lewiecki","year":"2008","journal-title":"Osteoporos Int"},{"key":"key-10.4103\/1319-2442.270256-21","doi-asserted-by":"crossref","unstructured":"Claes KJ, Viaene L, Heye S, Meijers B, d\u2019Haese P, Evenepoel P. Sclerostin: Another vascular calcification inhibitor? J Clin Endocrinol Metab 2013;98:3221-8.","DOI":"10.1210\/jc.2013-1521"},{"key":"key-10.4103\/1319-2442.270256-22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000366449","article-title":"Clinical and biological determinants of scierostin plasma concentration in hemodialysis patients","author":"Delanaye","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"key-10.4103\/1319-2442.270256-23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00223-012-9595-4","article-title":"Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): Relationship with bone density and arterial stiffness","author":"Thambiah","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"key-10.4103\/1319-2442.270256-24","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00198-011-1669-z","article-title":"Sclerostin levels during growth in children","author":"Kirmani","year":"2012","journal-title":"Osteoporos Int"},{"key":"key-10.4103\/1319-2442.270256-25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","author":"M\u00f6dder","year":"2011","journal-title":"J Bone Miner Res"},{"key":"key-10.4103\/1319-2442.270256-26","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1258\/acb.2012.011274","article-title":"Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, scierostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase","author":"Fischer","year":"2012","journal-title":"Ann Clin Biochem"},{"key":"key-10.4103\/1319-2442.270256-27","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","article-title":"Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis","author":"Bellido","year":"2005","journal-title":"Endocrinology"},{"key":"key-10.4103\/1319-2442.270256-28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2005.03.018","article-title":"SOST is a target gene for PTH in bone","author":"Keller","year":"2005","journal-title":"Bone"},{"key":"key-10.4103\/1319-2442.270256-29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bone.2007.03.017","article-title":"Molecular and cellular mechanisms of the anabolic effect of intermittent PTH","author":"Jilka","year":"2007","journal-title":"Bone"},{"key":"key-10.4103\/1319-2442.270256-30","first-page":"715908","article-title":"The effect of renal dysfunction on circulating sclerostin level in patients with type 2 diabetes","author":"Kim","year":"2014","journal-title":"Int J Endocrinol"},{"key":"key-10.4103\/1319-2442.270256-31","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","author":"Mirza","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1319-2442.270256-32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","author":"Gennari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1319-2442.270256-33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000443845","article-title":"High serum sclerostin levels are associated with a better outcome in haemo-dialysis patients","author":"Jean","year":"2016","journal-title":"Nephron"},{"key":"key-10.4103\/1319-2442.270256-34","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00467-007-0546-7","article-title":"Bone mineral density and bone histomorphometry in children on long-term dialysis","author":"Andrade","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.270256-35","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00467-004-1670-2","article-title":"Bone mineral density and bone turnover markers in children with chronic renal failure","author":"Bakr","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"key-10.4103\/1319-2442.270256-36","doi-asserted-by":"crossref","first-page":"i470","DOI":"10.1093\/ndt\/gfw190.52","article-title":"The results of noninvasive bone mineral density studies in children and adults with endstage renal failure on hemodialysis","author":"Shepetov","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"key-10.4103\/1319-2442.270256-37","doi-asserted-by":"crossref","unstructured":"Dr\u00fceke TB, Lafage-Proust MH. Sclerostin: Just one more player in renal bone disease? Clin J Am Soc Nephrol 2011;6:700-3.","DOI":"10.2215\/CJN.01370211"},{"key":"key-10.4103\/1319-2442.270256-38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/sdi.12415","article-title":"Sclerostin, osteo-cytes, and chronic kidney disease \u2013 Mineral bone disorder","author":"Moys\u00e9s","year":"2015","journal-title":"Semin Dial"},{"key":"key-10.4103\/1319-2442.270256-39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1210\/jc.2013-3168","article-title":"Sclerostin is positively associated with bone mineral density in men and women and negatively associated with carotid calcified atherosclerotic plaque in men from the African American-Diabetes Heart Study","author":"Register","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Saudi Journal of Kidney Diseases and Transplantation"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:37:22Z","timestamp":1786732642000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1319-2442.270256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"alternative-id":["270256"],"URL":"https:\/\/doi.org\/10.4103\/1319-2442.270256","relation":{},"ISSN":["1319-2442"],"issn-type":[{"value":"1319-2442","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}